Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
RIVER Trial Presented at #AHA20 / Twitter
Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis - American Journal of Cardiology
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
VisualAbstract: Rivaroxaban noninferior to warfarin in patients with atrial fibrillation and bioprosthetic mitral valves | 2 Minute Medicine
Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study. - Abstract - Europe PMC
PDF) RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH MECHANICAL HEART VALVE: PRELIMINARY RESULTS
Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis - ScienceDirect
PLOS ONE: Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users
Rivaroxaban is Comparable to Warfarin for Bioprosthetic Mitral Valves and AF | DAIC
Rivaroxaban in patients with mechanical heart valves: A pilot study - Thrombosis Research
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial - ScienceDirect
PLOS ONE: Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users
AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation and prosthetic valves - Cardiovascular News
![PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b848b4c36977bfee20ba4b3ed5bd220554206359/3-Figure1-1.png "PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar")
PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar
หนอนน้อยอ่านเปเปอร์ - Contraindications to the Use of Non–Vitamin K Oral Anticoagulants (ตามรูป) o Valvular atrial fibrillation (prosthetic valve, rheumatic mitral valvular disease, prior mitral valve repair) o Mechanical prosthetic heart valve o
Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study | SpringerLink
Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation - ScienceDirect
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
Warfarin in patients with mechanical heart valves | The BMJ
Home - ICHP KeePosted
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM
